These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9513604
1. Aminopyrimidines with high affinity for both serotonin and dopamine receptors. Wustrow D, Belliotti T, Glase S, Kesten SR, Johnson D, Colbry N, Rubin R, Blackburn A, Akunne H, Corbin A, Davis MD, Georgic L, Whetzel S, Zoski K, Heffner T, Pugsley T, Wise L. J Med Chem; 1998 Feb 26; 41(5):760-71. PubMed ID: 9513604 [Abstract] [Full Text] [Related]
2. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity. López-Rodríguez ML, Morcillo MJ, Rovat TK, Fernández E, Vicente B, Sanz AM, Hernández M, Orensanz L. J Med Chem; 1999 Jan 14; 42(1):36-49. PubMed ID: 9888831 [Abstract] [Full Text] [Related]
3. 3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists. Wustrow DJ, Smith WJ, Corbin AE, Davis MD, Georgic LM, Pugsley TA, Whetzel SZ, Heffner TG, Wise LD. J Med Chem; 1997 Jan 17; 40(2):250-9. PubMed ID: 9003524 [Abstract] [Full Text] [Related]
5. 1-aryl-4-[(5-methoxy-1,2,3, 4-tetrahydronaphthalen-1-yl)alkyl]piperazines and their analogues: influence of the stereochemistry of the tetrahydronaphthalen-1-yl nucleus on 5-HT1A receptor affinity and selectivity versus alpha1 and D2 receptors. 5. Perrone R, Berardi F, Colabufo NA, Leopoldo M, Tortorella V. J Med Chem; 1999 Feb 11; 42(3):490-6. PubMed ID: 9986719 [Abstract] [Full Text] [Related]
8. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G. J Pharmacol Exp Ther; 1998 Sep 11; 286(3):1341-55. PubMed ID: 9732398 [Abstract] [Full Text] [Related]
10. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S. J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651 [Abstract] [Full Text] [Related]
15. New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans. Mewshaw RE, Kavanagh J, Stack G, Marquis KL, Shi X, Kagan MZ, Webb MB, Katz AH, Park A, Kang YH, Abou-Gharbia M, Scerni R, Wasik T, Cortes-Burgos L, Spangler T, Brennan JA, Piesla M, Mazandarani H, Cockett MI, Ochalski R, Coupet J, Andree TH. J Med Chem; 1997 Dec 19; 40(26):4235-56. PubMed ID: 9435894 [Abstract] [Full Text] [Related]